Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

494 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of cancer of the prostate.
Catalona WJ. Catalona WJ. N Engl J Med. 1994 Oct 13;331(15):996-1004. doi: 10.1056/NEJM199410133311507. N Engl J Med. 1994. PMID: 7880240 Review. No abstract available.
Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.
Ratliff TL, Kavoussi LR, Catalona WJ. Ratliff TL, et al. Among authors: catalona wj. J Urol. 1988 Feb;139(2):410-4. doi: 10.1016/s0022-5347(17)42445-1. J Urol. 1988. PMID: 3276931
Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy.
Carvalhal GF, Humphrey PA, Thorson P, Yan Y, Ramos CG, Catalona WJ. Carvalhal GF, et al. Among authors: catalona wj. Cancer. 2000 Sep 15;89(6):1308-14. doi: 10.1002/1097-0142(20000915)89:6<1308::aid-cncr16>3.0.co;2-3. Cancer. 2000. PMID: 11002227
DNCB test in cancer patients.
Sadoff L, Glovsky M, Alenty A, Catalona WJ, Taylor PT, Chretien PB. Sadoff L, et al. Among authors: catalona wj. N Engl J Med. 1972 Jul 6;287(1):47-8. doi: 10.1056/NEJM197207062870117. N Engl J Med. 1972. PMID: 5029222 No abstract available.
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer.
Naughton M, Picus J, Zhu X, Catalona WJ, Vollmer RT, Humphrey PA. Naughton M, et al. Among authors: catalona wj. J Urol. 2001 Apr;165(4):1325-8. J Urol. 2001. PMID: 11257710
Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies.
Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Keetch DW, et al. Among authors: catalona wj. J Urol. 1996 Aug;156(2 Pt 1):428-31. doi: 10.1097/00005392-199608000-00025. J Urol. 1996. PMID: 8683695 Clinical Trial.
Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml.
Colberg JW, Smith DS, Catalona WJ. Colberg JW, et al. Among authors: catalona wj. J Urol. 1993 Mar;149(3):507-9. doi: 10.1016/s0022-5347(17)36130-x. J Urol. 1993. PMID: 7679753
Cancer of the prostate.
Catalona WJ. Catalona WJ. JAMA. 1992 Dec 9;268(22):3198; author reply 3199-200. doi: 10.1001/jama.268.22.3198b. JAMA. 1992. PMID: 1433754 No abstract available.
Radical surgery for advanced prostate cancer and for radiation failures.
Catalona WJ. Catalona WJ. J Urol. 1992 Mar;147(3 Pt 2):916. doi: 10.1016/s0022-5347(17)37421-9. J Urol. 1992. PMID: 1538496 No abstract available.
Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis.
Colberg JW, Andriole GL, Catalona WJ. Colberg JW, et al. Among authors: catalona wj. Br J Urol. 1997 Jan;79(1):54-7. doi: 10.1046/j.1464-410x.1997.29912.x. Br J Urol. 1997. PMID: 9043497
494 results
Jump to page
Feedback